Literature DB >> 31340099

Achieving Improved Survival Outcomes in Advanced Breast Cancer.

Hope S Rugo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31340099     DOI： 10.1056/NEJMe1906236

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer.

Authors:  Qian Xie; Hanrui Zheng; Qiu Li
Journal:  Breast Care (Basel)       Date:  2021-09-09       Impact factor: 2.268

2.  Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab.

Authors:  Vincenzo Quagliariello; Raffaele Vecchione; Alberta De Capua; Elena Lagreca; Rosario Vincenzo Iaffaioli; Gerardo Botti; Paolo A Netti; Nicola Maurea
Journal:  Int J Nanomedicine       Date:  2020-07-09

Review 3.  Relevance of Membrane Contact Sites in Cancer Progression.

Authors:  Aurora Gil-Hernández; Miguel Arroyo-Campuzano; Arturo Simoni-Nieves; Cecilia Zazueta; Luis Enrique Gomez-Quiroz; Alejandro Silva-Palacios
Journal:  Front Cell Dev Biol       Date:  2021-01-12

4.  Cardiovascular disease events within 5 years after a diagnosis of breast cancer.

Authors:  Benoîte Mery; Antoine Fouilloux; Elise Rowinski; Judith Catella-Chatron; Jean-Baptiste Guichard; Antoine Da Costa; Fabien Tinquaut; N Magné; Laurent Bertoletti
Journal:  BMC Cancer       Date:  2020-04-21       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.